Expanding HPV Vaccination: A New Era in Cancer Prevention for Men in Castilla y León
Castilla y León is extending its free HPV (Human Papillomavirus) vaccination program to include men up to the age of 25. This expansion aims to reach those who missed vaccination during adolescence and reduce the risk of HPV-related cancers in men. While current vaccination coverage is acceptable, it’s not optimal, with approximately two to three out of ten young men aged 15-18 remaining unvaccinated.
Addressing the Coverage Gap
Current data indicates that HPV vaccination coverage among 15-year-olds in Salamanca is around 73%, dipping slightly for older age groups. This falls short of the 90% coverage typically considered ideal for established childhood vaccination programs. Reaching young men becomes more challenging as they age, particularly after leaving compulsory education and entering the workforce. The extended age range to 25 provides a crucial second opportunity for vaccination.
Beyond Cervical Cancer: The Male Perspective
For years, HPV vaccination has been strongly associated with cervical cancer prevention in women. However, HPV is a common sexually transmitted infection that poses significant health risks to men as well. HPV can cause cancers of the penis, anus, and oropharynx (throat and mouth), as well as genital warts. Vaccinating men not only protects them individually but also reduces the overall circulation of the virus, benefiting their partners.
Why Vaccination Remains Effective in Young Adulthood
While many HPV infections are acquired early in sexual life, vaccination remains beneficial up to age 25. Many young adults haven’t been exposed to all HPV types included in the vaccine, meaning vaccination can still provide protection against new infections and reduce the risk of precancerous lesions. The extension to 25 years offers a pathway to reach young people no longer routinely seen in school-based vaccination programs, but who still utilize healthcare services.
Castilla y León’s Broader Cancer Prevention Efforts
This expansion of the HPV vaccination program is part of a larger initiative by Castilla y León to strengthen early cancer detection. In 2026, the region is allocating 1.5 million euros for HPV testing within its cervical cancer screening program, including 70,000 cytological diagnoses and 20,160 high-risk HPV determinations. This investment demonstrates a commitment to proactive cancer prevention strategies.
FAQ
Q: Who is eligible for the free HPV vaccine in Castilla y León?
A: Men up to 25 years of age.
Q: What cancers does HPV cause in men?
A: HPV can cause cancers of the penis, anus, and oropharynx (throat and mouth).
Q: Is the HPV vaccine effective if I’m already sexually active?
A: Yes, vaccination can still provide protection against HPV types you haven’t been exposed to.
Q: Where can I get more information about the HPV vaccine?
A: You can find more information on the Castilla y León health website: https://www.saludcastillayleon.es/es/vacunaciones/programa-vacunacion-frente-virus-papiloma-humano-vph
Did you know? In 2024, over 5,200 cases of high-risk HPV were detected in Castilla y León through screening programs.
Pro Tip: Talk to your healthcare provider to determine if the HPV vaccine is right for you and to schedule an appointment.
Stay informed about the latest health news and preventative measures. Explore our other articles on cancer prevention and public health initiatives in Castilla y León.